To further evaluate the kinetics of tumor cell killing, the samples included were divided into detectable precursor samples, with T-Ag–specific CD8+ T cells expanded from detectable levels to above 1%, and undetectable precursor samples, where T-Ag–specific T cells had been expanded from undetectable levels to below 1% of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.